Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes

被引:216
作者
Markova, Mariya [1 ,2 ]
Pivovarova, Olga [1 ,2 ,3 ]
Hornemann, Silke [1 ,2 ]
Sucher, Stephanie [1 ,2 ]
Frahnow, Turid [1 ,2 ]
Wegner, Katrin [4 ]
Machann, Juergen [2 ,5 ,6 ]
Petzke, Klaus Juergen [1 ]
Hierholzer, Johannes [7 ]
Lichtinghagen, Ralf [8 ]
Herder, Christian [2 ,9 ]
Carstensen-Kirberg, Maren [2 ,9 ]
Roden, Michael [2 ,9 ,10 ]
Rudovich, Natalia [1 ,2 ,3 ]
Klaus, Susanne [1 ]
Thomann, Ralph [11 ]
Schneeweiss, Rosemarie [12 ]
Rohn, Sascha [4 ,12 ]
Pfeiffer, Andreas F. H. [1 ,2 ,3 ]
机构
[1] German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany
[2] German Ctr Diabet Res, Dusseldorf, Germany
[3] Charite, Dept Endocrinol Diabet & Nutr, Campus Benjamin Franklin, Berlin, Germany
[4] Univ Hamburg, Inst Food Chem, Hamburg Sch Food Sci, Hamburg, Germany
[5] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany
[6] Univ Tubingen Hosp, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany
[7] Ernst von Bergmann Hosp, Dept Diagnost & Intervent Radiol, Potsdam, Germany
[8] Hannover Med Sch, Inst Clin Chem, Hannover, Germany
[9] German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany
[10] Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany
[11] Inst Getreideverarbeitung GmbH, Nuthetal, Germany
[12] Inst Food & Environm Res, Nuthetal, Germany
关键词
KLB; FFA; NAFLD; NASH; GROWTH-FACTOR; 21; HEPATIC INSULIN-RESISTANCE; CHAIN AMINO-ACIDS; ADIPOSE-TISSUE; LIPID-METABOLISM; FGF21; DISEASE; OBESITY; MEN; EXPRESSION;
D O I
10.1053/j.gastro.2016.10.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is associated with increased risk of hepatic, cardiovascular, and metabolic diseases. High-protein diets, rich in methionine and branched chain amino acids (BCAAs), apparently reduce liver fat, but can induce insulin resistance. We investigated the effects of diets high in animal protein (AP) vs plant protein (PP), which differ in levels of methionine and BCAAs, in patients with type 2 diabetes and NAFLD. We examined levels of liver fat, lipogenic indices, markers of inflammation, serum levels of fibroblast growth factor 21 (FGF21), and activation of signaling pathways in adipose tissue. METHODS: We performed a prospective study of individuals with type 2 diabetes and NAFLD at a tertiary medical center in Germany from June 2013 through March 2015. We analyzed data from 37 subjects placed on a diet high in AP (rich in meat and dairy foods; n = 18) or PP (mainly legume protein; n = 19) without calorie restriction for 6 weeks. The diets were isocaloric with the same macronutrient composition (30% protein, 40% carbohydrates, and 30% fat). Participants were examined at the start of the study and after the 6-week diet period for body mass index, body composition, hip circumference, resting energy expenditure, and respiratory quotient. Body fat and intrahepatic fat were detected by magnetic resonance imaging and spectroscopy, respectively. Levels of glucose, insulin, liver enzymes, and inflammation markers, as well as individual free fatty acids and free amino acids, were measured in collected blood samples. Hyperinsulinemic euglycemic clamps were performed to determine whole-body insulin sensitivity. Subcutaneous adipose tissue samples were collected and analyzed for gene expression patterns and phosphorylation of signaling proteins. RESULTS: Postprandial levels of BCAAs and methionine were significantly higher in subjects on the AP vs the PP diet. The AP and PP diets each reduced liver fat by 36%-48% within 6 weeks (for AP diet P = .0002; for PP diet P = .001). These reductions were unrelated to change in body weight, but correlated with down-regulation of lipolysis and lipogenic indices. Serum level of FGF21 decreased by 50% in each group (for AP diet P < .0002; for PP diet P < .0002); decrease in FGF21 correlated with loss of hepatic fat. In gene expression analyses of adipose tissue, expression of the FGF21 receptor cofactor beta-klotho was associated with reduced expression of genes encoding lipolytic and lipogenic proteins. In patients on each diet, levels of hepatic enzymes and markers of inflammation decreased, insulin sensitivity increased, and serum level of keratin 18 decreased. CONCLUSIONS: In a prospective study of patients with type 2 diabetes, we found diets high in protein (either animal or plant) significantly reduced liver fat independently of body weight, and reduced markers of insulin resistance and hepatic necroinflammation. The diets appear to mediate these changes via lipolytic and lipogenic pathways in adipose tissue. Negative effects of BCAA or methionine were not detectable. FGF21 level appears to be a marker of metabolic improvement. ClinicalTrials.gov ID NCT02402985.
引用
收藏
页码:571 / +
页数:23
相关论文
共 58 条
  • [1] Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
    Birkenfeld, Andreas L.
    Shulman, Gerald I.
    [J]. HEPATOLOGY, 2014, 59 (02) : 713 - 723
  • [2] Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
    Bjermo, Helena
    Iggman, David
    Kullberg, Joel
    Dahlman, Ingrid
    Johansson, Lars
    Persson, Lena
    Berglund, Johan
    Pulkki, Kari
    Basu, Samar
    Uusitupa, Matti
    Rudling, Mats
    Arner, Peter
    Cederholm, Tommy
    Ahlstrom, Hakan
    Riserus, Ulf
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 95 (05) : 1003 - 1012
  • [3] Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients
    Bortolotti, Murielle
    Maiolo, Elena
    Corazza, Mattia
    Van Dijke, Eveline
    Schneiter, Philippe
    Boss, Andreas
    Carrel, Guillaume
    Giusti, Vittorio
    Le, Kim-Anne
    Chong, Daniel Guae Quo
    Buehler, Tania
    Kreis, Roland
    Boesch, Chris
    Tappy, Luc
    [J]. CLINICAL NUTRITION, 2011, 30 (04) : 494 - 498
  • [4] High protein intake reduces intrahepatocellular lipid deposition in humans
    Bortolotti, Murielle
    Kreis, Roland
    Debard, Cyrille
    Cariou, Bertrand
    Faeh, David
    Chetiveaux, Maud
    Ith, Michael
    Vermathen, Peter
    Stefanoni, Nathalie
    Le, Kim-Anne
    Schneiter, Philippe
    Krempf, Michel
    Vidal, Hubert
    Boesch, Chris
    Tappy, Luc
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 90 (04) : 1002 - 1010
  • [5] Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis
    Bradbury, MW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (02): : G194 - G198
  • [6] Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
    Bugianesi, E
    Gastaldelli, A
    Vanni, E
    Gambino, R
    Cassader, M
    Baldi, S
    Ponti, V
    Pagano, G
    Ferrannini, E
    Rizzetto, M
    [J]. DIABETOLOGIA, 2005, 48 (04) : 634 - 642
  • [7] Novel locus including FGF21 is associated with dietary macronutrient intake
    Chu, Audrey Y.
    Workalemahu, Tsegaselassie
    Paynter, Nina P.
    Rose, Lynda M.
    Giulianini, Franco
    Tanaka, Toshiko
    Ngwa, Julius S.
    Qi, Qibin
    Curhan, Gary C.
    Rimm, Eric B.
    Hunter, David J.
    Pasquale, Louis R.
    Ridker, Paul M.
    Hu, Frank B.
    Chasman, Daniel I.
    Qi, Lu
    [J]. HUMAN MOLECULAR GENETICS, 2013, 22 (09) : 1895 - 1902
  • [8] Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
    Dushay, Jody
    Chui, Patricia C.
    Gopalakrishnan, Gosala S.
    Varela-Rey, Marta
    Crawley, Meghan
    Fisher, Ffolliott M.
    Badman, Michael K.
    Martinez-Chantar, Maria L.
    Maratos-Flier, Eleftheria
    [J]. GASTROENTEROLOGY, 2010, 139 (02) : 456 - 463
  • [9] Fructose ingestion acutely stimulates circulating FGF21 levels in humans
    Dushay, Jody R.
    Toschi, Elena
    Mitten, Emilie K.
    Fisher, Ffolliott M.
    Herman, Mark A.
    Maratos-Flier, Eleftheria
    [J]. MOLECULAR METABOLISM, 2015, 4 (01): : 51 - 57
  • [10] Alterations in Fatty Acid Kinetics in Obese Adolescents With Increased Intrahepatic Triglyceride Content
    Fabbrini, Elisa
    deHaseth, Dinky
    Deivanayagam, Sheela
    Mohammed, B. Selma
    Vitola, Bernadette E.
    Klein, Samuel
    [J]. OBESITY, 2009, 17 (01) : 25 - 29